About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
JB Chemicals & Pharmaceuticals Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
506943
ISIN Demat
INE572A01036
Book Value
243.11
NSE Code
JBCHEPHARM
Dividend Yield %
0.84
Market Cap
297056.22
P/E
40.84
EPS
45.31
Face Value
1
BSE
NSE
06-Feb-2026
BSE
NSE
NSE F & O
06-Feb-2026
BSE
NSE
NSE F & O
Last Price
1850.50
Net Change
-6.7
% Change
-0.36%
Prev.Close
1857.20
Open
1825.35
High
1858.55
Low
1825.35
Volume
492
Last Price
1849.50
Net Change
-8.1
% Change
-0.44%
Prev.Close
1857.60
Open
1844.00
High
1859.30
Low
1839.20
Volume
163418
Value
910845
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
1858.55
52-Week High
1939.30
52-Week Low
1303.00
Value
302191032.2
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
1859.30
52-Week High
1939.00
52-Week Low
1385.75
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Book Closure
18-Aug-23
24-Aug-23
Dividend
1270 %
11-Feb-26
Company News
22-01-2026
JB Chemicals & Pharmaceu...
22-01-2026
JB Chemicals & Pharmaceut...
21-01-2026
JB Chemicals & Pharmaceut...
16-12-2025
JB Chemicals & Pharmaceut...
09-12-2025
Updates on Open Offer
17-11-2025
Updates on Open Offer
07-11-2025
Letter of Offer
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.
